Stock Market

Short-seller Hindenburg Research’s bearish call on Elon Musk’s Twitter (TWTR) takeover deal paid off. There’s now a good chance the $54.20 per-share deal doesn’t go through as is. Still, if TWTR stock continues to slide, risk/return could again become favorable with this merger arbitrage situation. Source: rafapress / Shutterstock.com Merger arbitrage, essentially the wagering on
0 Comments
These five upcoming initial public offerings (IPOS) are among the most promising ones to watch. They will make headlines and offer volatile stock trading with elevated valuations and risk. Reddit: Is the communities’ network that was at the center of meme trading. Discord: Provides a platform for people to communicate via voice, video and text
0 Comments
Ever since listing, there were doubts on the valuation that Robinhood (NASDAQ:HOOD) stock commanded. After an initial spike, HOOD stock has remained in a downtrend. Several factors have contributed to the massive selling in the last six-months with the stock plunging by 75% during this period. I must admit that I didn’t expect HOOD stock
0 Comments
The entire EV market is getting a boost today. From Rivian (NASDAQ:RIVN) to Tesla (NASDAQ:TSLA) to Lucid (NASDAQ:LCID), risk-on sentiment finally appears to be taking hold this Friday. Among the major electric vehicle (EV) makers that are seeing impressive increases, Lucid is a leader. On Friday, LCID stock soared more than 16% around noon EST as investors returned to
0 Comments
Warner Bros Discovery (NASDAQ:WBD), the new entertainment giant formed on April 8 from the combination of Discovery Inc. and WarnerMedia, is set to become the second-largest media player by revenue after Walt Disney (NYSE:DIS). Since the merger, WBD stock has dropped faster than the equity markets in general, losing more than 30% year-to-date, but it is rebounding
0 Comments
Upstart (NASDAQ:UPST) stock lost over half its value in a single day after cutting its full-year revenue outlook The company is growing revenue and income at a fast clip despite economic headwinds UPST stock is a bargain, but that doesn’t mean shares will move higher Source: Postmodern Studio / Shutterstock.com I bought the dip in
0 Comments
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments